<DOC>
	<DOCNO>NCT00607867</DOCNO>
	<brief_summary>We determine metabolic response Low Biologically Available Glucose Diet ( LoBAG30 ) subject currently receive maximum dose metformin monotherapy glycohemoglobin acceptable level ( &gt; 8.0 % ) . Our hypothesis introduction LoBAG30 diet subject currently treat full therapeutic dose metformin improve blood glucose control people achieve acceptable total glycohemoglobin metformin alone .</brief_summary>
	<brief_title>LoBAG30 Diet Patients Metformin</brief_title>
	<detailed_description>Subjects ingest control diet ( 55 % carbohydrate ( CHO ) , 15 % protein , 30 % fat ) LoBAG30 diet ( 30 % CHO , 30 % protein , 40 % fat ) parallel design block randomization pair two . Subjects return study center twice week diet blood glucose , glycohemoglobin , lactate , weight blood pressure measure , urine assay urea creatinine . At begin end 5 week study period , subject admit study center 28 hour time blood drawn 24 hour profile glucose , insulin , hormones several metabolite . For subject randomize LoBAG30 arm study , control diet give first 24 hour study period ; assign diet give end 5 week period .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>People type 2 diabetes mellitus currently receive maximal dose metformin monotherapy ( 2500 mg/day ) . These subject stable glycohemoglobin ( tGHb ) unacceptably high range ( 811 % ) least 4 month prior begin study . Subjects tGHB &gt; 11 % ( HbA1c &gt; 10 % ) recruit study . Hematological abnormalities liver disease kidney disease macroalbuminuria ( &gt; 300 mg albumin/24 hour ) untreated thyroid disease congestive heart failure angina lifethreatening malignancy proliferative retinopathy severe diabetic neuropathy peripheral vascular disease serious psychological disorder body mass index &gt; 35 fast triglyceride &gt; 400 mg/dl . Subjects take slowrelease metformin study . Subjects take medication metformin , know affect fuel metabolism : insulin sulfonylurea glucagonlike peptide 1 ( GLP1 ) analogs metabolic inhibitor pramlintide prednisone similar steroid thyroid hormone antipsychotic medication thiazide diuretic medroxyprogesterone high dose aspirin , also exclude . If concentration serum folate , B12 iron low , subject exclude study correct , i.e . normal concentration record .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Diabetes Mellitus ( type 2 )</keyword>
	<keyword>Diet</keyword>
	<keyword>Glycohemoglobin</keyword>
	<keyword>Lipids</keyword>
	<keyword>Kidney Function</keyword>
	<keyword>Glycemic Index</keyword>
	<keyword>Dietary Protein</keyword>
	<keyword>Dietary Carbohydrate</keyword>
</DOC>